Regenexx Publishes Mid-term Results of Its Randomized Controlled Trial Showing Its Perc-ACLR Procedure Can Help Patients Avoid Surgical ACL Reconstruction
DES MOINES, Iowa, Aug. 10, 2022 /PRNewswire/ — Regenexx®, a research-driven interventional orthobiologics network of physicians performing regenerative…